Mark A. Herman, MD

Associate Professor of Medicine
Assistant Research Professor in Pharmacology and Cancer Biology
Member of Duke Molecular Physiology Institute
Campus mail 300 N. Duke Street, Carmichael Building, Durham, NC 27701
Phone (919) 479-2378

Education and Training

  • Endocrinology Fellowship, Beth Israel Deaconess Medical Center, 2003 - 2006
  • Internal Medicine Residency, University of Texas Southwestern Medical Center, Medical School, 2000 - 2003
  • M.D., University of Texas Southwestern Medical Center, Medical School, 2000

Publications

Doridot, Ludivine, Sarah A. Hannou, Sarah A. Krawczyk, Wenxin Tong, Mi-Sung Kim, Gregory S. McElroy, Alan J. Fowler, Inna I. Astapova, and Mark A. Herman. “A Systems Approach Dissociates Fructose-Induced Liver Triglyceride from Hypertriglyceridemia and Hyperinsulinemia in Male Mice.” Nutrients 13, no. 10 (October 18, 2021). https://doi.org/10.3390/nu13103642.

PMID
34684643
Full Text

White, Phillip J., Robert W. McGarrah, Mark A. Herman, James R. Bain, Svati H. Shah, and Christopher B. Newgard. “Insulin action, type 2 diabetes, and branched-chain amino acids: A two-way street.” Mol Metab 52 (October 2021): 101261. https://doi.org/10.1016/j.molmet.2021.101261.

PMID
34044180
Full Text

Haslam, Danielle E., Gina M. Peloso, Melanie Guirette, Fumiaki Imamura, Traci M. Bartz, Achilleas N. Pitsillides, Carol A. Wang, et al. “Sugar-Sweetened Beverage Consumption May Modify Associations Between Genetic Variants in the CHREBP (Carbohydrate Responsive Element Binding Protein) Locus and HDL-C (High-Density Lipoprotein Cholesterol) and Triglyceride Concentrations.” Circ Genom Precis Med 14, no. 4 (August 2021): e003288. https://doi.org/10.1161/CIRCGEN.120.003288.

PMID
34270325
Full Text

SARGSYAN, A. S. H. O. T., L. U. D. I. V. I. N. E. DORIDOT, SARAH A. HANNOU, W. E. N. X. I. N. TONG, H. A. R. I. N. I. SRINIVASAN, R. A. C. H. A. E. L. IVISON, R. U. B. Y. MONN, et al. “205-LB: HGFAC Is a ChREBP-Regulated Hepatokine That Enhances Glucose and Lipid Homeostasis.” In Diabetes, Vol. 70. American Diabetes Association, 2021. https://doi.org/10.2337/db21-205-lb.

Full Text

Katz, Liora S., Sharon Baumel-Alterzon, Donald K. Scott, and Mark A. Herman. “Adaptive and maladaptive roles for ChREBP in the liver and pancreatic islets.” J Biol Chem 296 (January 2021): 100623. https://doi.org/10.1016/j.jbc.2021.100623.

PMID
33812993
Full Text

Capozzi, Megan E., Reilly W. Coch, Jepchumba Koech, Inna I. Astapova, Jacob B. Wait, Sara E. Encisco, Jonathan D. Douros, et al. “The Limited Role of Glucagon for Ketogenesis During Fasting or in Response to SGLT2 Inhibition.” Diabetes 69, no. 5 (May 2020): 882–92. https://doi.org/10.2337/db19-1216.

PMID
32005706
Full Text

Ezaz, Ghideon, Hirsh D. Trivedi, Margery A. Connelly, Claudia Filozof, Kellie Howard, Mark L Parrish, Misung Kim, et al. “Differential Associations of Circulating MicroRNAs With Pathogenic Factors in NAFLD.” Hepatol Commun 4, no. 5 (May 2020): 670–80. https://doi.org/10.1002/hep4.1501.

PMID
32363318
Full Text

Haslam, Danielle E., Gina M. Peloso, Mark A. Herman, Josée Dupuis, Alice H. Lichtenstein, Caren E. Smith, and Nicola M. McKeown. “Beverage Consumption and Longitudinal Changes in Lipoprotein Concentrations and Incident Dyslipidemia in US Adults: The Framingham Heart Study.” J Am Heart Assoc 9, no. 5 (March 3, 2020): e014083. https://doi.org/10.1161/JAHA.119.014083.

PMID
32098600
Full Text

Pages